Biotech Investors & VC Firms in Global
911 firms in this list, with a median first check of $500K. 234 of them lead rounds. Generated from verified public data and updated continuously.
Swanlaab Venture Factory
MadridSeed–Series A$540K – $3.2M
23 people
Blue Ocean Capital Group
ShenzhenLate Stage
31 people
HAWKTAIL
San FranciscoSeed–Series A
4 people
HCVC
ParisPre-Seed–Series A$100K – $1M
7 people
Peregrine Ventures
Or YehudaSeed–Growth$500K – $3M
16 people
Intrepid Growth Partners
TorontoGrowth
28 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
Verge HealthTech Fund
SingaporePre-Seed–Series A$500K – $1.5M
24 people
ZAKA VC
San FranciscoPre-Seed–Seed
13 people
Version One Ventures
VancouverPre-Seed–Seed$250K – $500K
4 people
SVG Ventures | THRIVE
Santa ClaraPre-Seed–Series A$10K – $100K
27 people
Start Capital
Pre-Seed–Series A
7 people
Lauder Partners
Los AltosSeed–Growth
1 person
MassChallenge Mexico
BostonPre-Seed–Series A
31 people
Bay City Capital
San RafaelSeed–Late Stage$5M – $10M
8 people
Vibe Capital
San FranciscoPre-Seed–Series A$250K – $500K
3 people
IDG Capital
Hong KongPre-Seed–Late Stage$1M – $100M
8 people
Lever VC
New YorkPre-Seed–Series A$100K – $5M
17 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
Transform Capital Management
San FranciscoPre-Seed–Seed
22 people
Trendlines Group
MisgavPre-Seed–Seed
20 people
Ankur Capital
MumbaiPre-Seed–Series A$500K – $2M
18 people
Alta Partners
San FranciscoSeed–Series A$1M – $12M
10 people
Georgian
Toronto, OntarioSeries C–Growth$25M – $100M
18 people
Related lists
Investors & VC Firms in North America (13118)Investors & VC Firms in United States (12145)Investors & VC Firms in Europe (5954)AI & Machine Learning Investors & VC Firms (5127)Investors & VC Firms in Global (5099)Fintech Investors & VC Firms (4949)Healthtech Investors & VC Firms (4486)SaaS Investors & VC Firms (4408)Enterprise Software Investors & VC Firms (4306)Crypto & Web3 Investors & VC Firms (4087)
Data sourced from public filings and firms' own websites — see our methodology.





































































































